Processing

Please wait...

Settings

Settings

Goto Application

1. WO1999003854 - CRYSTAL MODIFICATION OF A N-PHENYL-2-PYRIMIDINEAMINE DERIVATIVE, PROCESSES FOR ITS MANUFACTURE AND ITS USE

Publication Number WO/1999/003854
Publication Date 28.01.1999
International Application No. PCT/EP1998/004427
International Filing Date 16.07.1998
Chapter 2 Demand Filed 18.12.1998
IPC
C07D 401/04 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
401Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
02containing two hetero rings
04directly linked by a ring-member-to-ring- member bond
CPC
A61P 11/08
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
11Drugs for disorders of the respiratory system
08Bronchodilators
A61P 17/06
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
17Drugs for dermatological disorders
06Antipsoriatics
A61P 31/04
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
04Antibacterial agents
A61P 35/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35Antineoplastic agents
A61P 43/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
43Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
A61P 7/02
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
7Drugs for disorders of the blood or the extracellular fluid
02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Applicants
  • NOVARTIS AG [CH]/[CH] (AL, AM, AU, AZ, BA, BB, BE, BF, BG, BJ, BR, BY, CA, CF, CG, CH, CI, CM, CN, CU, CY, CZ, DE, DK, EE, ES, FI, FR, GA, GB, GE, GH, GM, GN, GR, GW, HR, HU, ID, IE, IL, IS, IT, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MC, MD, MG, MK, ML, MN, MR, MW, MX, NE, NL, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, SN, SZ, TD, TG, TJ, TM, TR, TT, UA, UG, UZ, VN, YU, ZW)
  • NOVARTIS-ERFINDUNGEN VERWALTUNGSGESELLSCHAFT MBH [AT]/[AT] (AT)
  • ZIMMERMANN, Jürg [CH]/[CH] (UsOnly)
  • SUTTER, Bertrand [FR]/[FR] (UsOnly)
  • BÜRGER, Hans, Michael [DE]/[CH] (UsOnly)
Inventors
  • ZIMMERMANN, Jürg
  • SUTTER, Bertrand
  • BÜRGER, Hans, Michael
Agents
  • BECKER, Konrad
Priority Data
1764/9718.07.1997CH
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) CRYSTAL MODIFICATION OF A N-PHENYL-2-PYRIMIDINEAMINE DERIVATIVE, PROCESSES FOR ITS MANUFACTURE AND ITS USE
(FR) MODIFICATION DE LA FORME CRISTALLINE D'UN DERIVE N-PHENYL-2-PYRIMIDINEAMINE, PROCEDE DE PREPARATION ET D'UTILISATION DE CE DERNIER
Abstract
(EN)
The invention relates to a new crystalline form of the methanesulfonic acid addition salt of 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide of formula (I), which may be used for example for tumour therapy.
(FR)
Cette invention concerne une nouvelle forme cristalline du sel d'addition acide du méthane sulfonique de 4-(4-méthylepiperazine-1-ylméthyle)-N-[4-méthyle-3-(4-pyridine-3-yl)pyrimidine-2-ylamino)phényle]-benzamide de formule (I) qui peut être utilisée par exemple pour la thérapie antitumorale.
Latest bibliographic data on file with the International Bureau